MedTrace Logo

The Sex-Specific Impact of a Single Foam Rolling Session on Peripheral Muscle Oxygenation

NCT07078448 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-09-23

No results posted yet for this study

Summary

The hamstring muscle, as a biarticular muscle, plays a crucial role in both hip extension and knee flexion and is part of the Superficial Back Line, which supports upright posture and prevents excessive flexion. Its continuous postural function requires endurance-oriented muscle fibers and sustained low-level muscle tone. Tightness in the hamstrings is commonly linked to postural imbalances and structural factors, contributing to gait alterations, low back pain, tendinopathy, and other musculoskeletal disorders. Improving hamstring flexibility is important for performance and injury prevention, with myofascial release-particularly self-myofascial release using foam rollers-being an effective method. Foam rolling reduces muscle tension, enhances tissue hydration, and may alleviate fascial adhesions. However, sex differences exist in connective tissue properties, potentially influencing outcomes. Limited research has explored foam rolling's impact on peripheral muscle oxygenation. This study aims to investigate the effect of foam rolling on hamstring muscle oxygen saturation in recreational individuals with tightness, with a hypothesis that females may show greater increases.

Conditions

  • Hamstring Muscles
  • Hamstring Shortness
  • Hamstring Tightness

Interventions

OTHER

Foam Roller

FR will be applied to each hamstring muscle for 3 minutes per leg, totaling 6 minutes. The pressure was self-regulated by participants, who are instructed to apply as much body weight as tolerable. The rolling frequency is maintained at approximately 0.5 Hz, corresponding to one complete rolling cycle every 2 seconds. Before the intervention, participants will receive verbal and visual instructions to ensure correct execution.

Sponsors & Collaborators

  • Pelin Pişirici

    lead OTHER

Principal Investigators

  • Gökhan Koçak, MD · Medipol University

  • Pelin Pişirici, PT, PhD · Bahcesehir University, Faculty of Health Sciences

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2025-08-01
Completion
2025-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07078448 on ClinicalTrials.gov